
INmune Bio Inc (INMB) with a beta value of 1.05 appears to be a promising investment opportunity.
A new trading day began on Friday, with INmune Bio Inc (NASDAQ: INMB) stock price down -8.24% from the previous day of trading, before settling
A new trading day began on Friday, with INmune Bio Inc (NASDAQ: INMB) stock price down -8.24% from the previous day of trading, before settling
INmune Bio Inc (NASDAQ: INMB) on Friday, plunged -6.23% from the previous trading day, before settling in for the closing price of $2.73. Within the
On Monday, INmune Bio Inc (NASDAQ: INMB) opened higher 7.38% from the last session, before settling in for the closing price of $2.71. Price fluctuations
As on Wednesday, INmune Bio Inc (NASDAQ: INMB) got off with the flyer as it spiked 19.17% to $2.86, before settling in for the price
INmune Bio Inc (NASDAQ: INMB) open the trading on Thursday, with a bit cautious approach as it glided -4.27% to $2.24, before settling in for
A new trading day began on Monday, with INmune Bio Inc (NASDAQ: INMB) stock price down -8.23% from the previous day of trading, before settling
INmune Bio Inc (NASDAQ: INMB) flaunted slowness of -5.51% at $2.23, as the Stock market unbolted on Thursday, before settling in for the price of
INmune Bio Inc (NASDAQ: INMB) started the day on Wednesday, with a price increase of 12.92% at $2.36, before settling in for the price of
INmune Bio Inc (NASDAQ: INMB) on Monday, plunged -15.13% from the previous trading day, before settling in for the closing price of $6.28. Within the
A new trading day began on Tuesday, with INmune Bio Inc (NASDAQ: INMB) stock price up 6.27% from the previous day of trading, before settling
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.